about
A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal AdenocarcinomaAptamer in bioanalytical applications.HAPIscreen, a method for high-throughput aptamer identification.Aptamer-targeted cell-specific RNA interferenceAptamer-targeted antigen delivery.Hybrid compounds: from simple combinations to nanomachines.Promising new assays and technologies for the diagnosis and management of infectious diseasesCell-specific aptamer-mediated targeted drug deliveryAptamers: new arrows to target dendritic cells.Optimizing siRNA delivery to the genital mucosasiRNA-based topical microbicides targeting sexually transmitted infections.Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell GrowthEmerging molecular targets for brain repair after strokeThe emerging role of epigenetics in stroke: II. RNA regulatory circuitry.Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL.Non-viral nanovectors for gene delivery: factors that govern successful therapeutics.Novel drugs to treat hemophilia.Receptor-targeted nanocarriers for therapeutic delivery to cancer.Aptamer-dendrimer bioconjugate: a nanotool for therapeutics, diagnosis, and imaging.Surface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges.Modular Assembly of Cell-targeting Devices Based on an Uncommon G-quadruplex Aptamer.RNA aptamers and their therapeutic and diagnostic applications.Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies.Orchestrating a Symphony on a Single Conjugate: Aptamer Targeting, Gene Silencing, and Immunomodulation to Enhance Antitumor Response.Selection and Identification of Skeletal-Muscle-Targeted RNA Aptamers.Highly efficient enzymatic synthesis of 3'-deoxyapionucleic acid (apioNA) having the four natural nucleobases.Biocompatible cationic lipids for the formulation of liposomal DNA vectors
P2860
Q30275702-68EE329D-1B52-485B-8DA7-F5FA132FD079Q30466572-1F06FC6F-EF8B-440E-8AAD-FC134014D10EQ31015710-E490A4DD-7893-4C67-A25D-DCEDA539ACA0Q33717239-A512CEFF-1FA0-439C-B914-B407D060E5CDQ33870736-B60ECCDE-0F03-4A72-B492-EA66ACF408BFQ34125590-B3A5CC09-BBBC-4EF9-934A-C0D8928CE5EEQ34504281-1F0C9A5D-A862-4D7B-865B-C0EDAFD0546AQ34599718-F043B8C7-C380-4B60-88C9-E32D25A79420Q35624065-78588A6D-C056-49FF-871F-8C192D04E44EQ35766249-C42AC05F-2B61-482F-BC03-1EA001F2AC8BQ35766254-7C3AC79B-DECE-42D2-B2BF-96742F195A06Q36316911-46805E82-1ABC-4E41-9587-F61CE4E83935Q36567408-17A00DB2-98BE-4768-AD23-AB57FA14F1A1Q36886962-063AA0B6-A135-42FD-85E6-5626D2BDE7EFQ37238771-EB1C3BFE-F91E-4D40-8734-DC85674AC741Q37724374-25DC66A7-4041-4B9E-8295-56FB818F48CDQ37775029-E1536312-40E1-445A-AD05-978FFDE593FCQ37804383-C9D2B848-E818-46FD-9776-C4AFD6C397BFQ38035033-F93D9C1A-A296-410F-BDF8-21615BD334C2Q38899902-828CCED5-E8D0-4799-9042-190C4309195EQ38968703-A0A1C3C5-9CB2-4DBB-8478-AD5979AFD516Q39862703-2B38F3DA-93FF-418B-AB56-2AB4C3183567Q40976323-6DFFB75F-33F1-493D-8F5C-B045915E69E7Q47566766-D5F0DC7C-4898-4CA6-93FD-EAFA1BD6FA04Q52676614-4EDAC5C1-116D-4391-B8D8-D241E3F72B47Q54577097-CA1E13A8-D693-4E8A-9C7C-F48708C8BA48Q58046777-79236462-3B07-4656-A783-1ED3F3437732
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aptamers and aptamer targeted delivery.
@en
Aptamers and aptamer targeted delivery.
@nl
type
label
Aptamers and aptamer targeted delivery.
@en
Aptamers and aptamer targeted delivery.
@nl
prefLabel
Aptamers and aptamer targeted delivery.
@en
Aptamers and aptamer targeted delivery.
@nl
P2860
P356
P1433
P1476
Aptamers and aptamer targeted delivery.
@en
P2093
P2860
P304
P356
10.4161/RNA.6.3.8808
P577
2009-07-18T00:00:00Z